stockrowDr. Reddy's Laboratories Ltd (RDY) vs Indivior Pharmaceuticals Inc. (SUPN)
- Dr. Reddy's Laboratories Ltd RDY 14.53 −1.62%
- Indivior Pharmaceuticals Inc. SUPN 28.21 +0.21%
Dr. Reddy's Laboratories Ltd and Indivior Pharmaceuticals Inc. are both Drug Manufacturers Specialty & Generic companies. Dr. Reddy's Laboratories Ltd is the larger, with a market value of $12.1B against $5.6B — 2.2× the size. Indivior Pharmaceuticals Inc. trades at the lower P/E: 7.6× against 44.4×. Indivior Pharmaceuticals Inc. grew revenue faster over the last twelve months: 16.4% against −15.5%. Indivior Pharmaceuticals Inc. has the higher net margin (32.9% vs 8.06%) and the higher return on invested capital (283.0% vs 4.77%). Neither pays a dividend. Across the 21 metrics below, Indivior Pharmaceuticals Inc. leads on 16 and Dr. Reddy's Laboratories Ltd on 5.
Valuation
Profitability
| Metric | RDY | SUPN | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 49.16% | 84.85% | 53.51% |
| Operating margin | 9.20% | 40.57% | 0.00% |
| Net margin | 8.06% | 32.85% | (2.45%) |
| Free cash flow margin | 2.88% | 2.26% | 0.00% |
| Return on equity | 6.60% | (337.83%) | (0.80%) |
| Return on assets | 4.44% | 32.82% | (1.67%) |
| Return on invested capital | 4.77% | 283.03% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack